Turning Point Therapeutics: Q2 Earnings Snapshot
SAN DIEGO (AP) _ Turning Point Therapeutics Inc. (TPTX) on Monday reported a loss of $123.1 million in its second quarter.
The San Diego-based company said it had a loss of $2.48 per share.
The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.78 per share.
The biopharmaceutical company posted revenue of $119,000 in the period.